Resumo

Objectives: To evaluate the effectiveness of multimodal, minimally invasive strategies in female intimate rejuvenation. This review identifies how combining energy devices with biologics and injectables can optimize outcomes in GSM, laxity, and sexual dysfunction, offering physicians evidence-based insights to improve patient satisfaction and treatment planning. Introduction: Female intimate aging leads to GSM, laxity, and sexual dysfunction, impacting quality of life. While monotherapies such as lasers, RF, or injectables provide benefit, emerging evidence suggests combination approaches achieve superior results. Understanding these strategies is key to advancing non-surgical management and enhancing functional and aesthetic outcomes. Materials / method: A clinical review (2021–2025) was conducted on minimally invasive protocols including RF, CO₂/Er:YAG lasers, hyaluronic acid injectables, platelet-rich plasma, and pelvic floor electromagnetic stimulation. Outcomes were assessed across validated measures (FSFI, VHI, VLQ, GAIS), focusing on both single and combination modalities to determine synergistic benefits. Results: Combination therapies outperformed monotherapies in multiple trials. RF+HA improved all FSFI domains and collagen density. RF+PEMF yielded significant VLQ and pelvic floor strength gains versus sham. CO₂ laser+PRP increased lubrication, orgasm frequency, and dyspareunia relief. Patient satisfaction exceeded 80% across studies, with safety profiles consistently favorable and only mild transient side effects reported. Conclusion: Multimodal strategies provide greater clinical benefit than single modalities, addressing hydration, tissue support, neurosensory function, and pelvic stability simultaneously. Evidence supports RF+HA and RF+PEMF as highly effective, with laser+PRP showing strong promise. Individualized protocols and further high-level trials are needed to standardize regimens and confirm long-term efficacy in intimate rejuvenation.